检索历史 清除

目的 提高恶性肿瘤患者的生存质量,研究肿瘤学、心理学和社会医学相结合的多学科综合干预措施对生存时间的影响.方法 639例恶性肿瘤患者随机分为干预组和对照组.干预组采用专家指导下的系统抗癌和群体抗癌相结合的方法进行健康干预,干预期为2年.而对照组则处于自行康复状态.2年后,调查两组生存状况,分析两组在肿瘤各期的两年生存率的差异,Cox比例风险模型分析生存数据的影响.对两组的一般情况和疾病相关因素间的均衡性进行了统计学检验.结果 干预后随访到的研究对象为254例(随访率为93.38%),对照组为330例(随访率89.91%).Ⅱ期肿瘤患者干预组的两年生存率94.74%(108/114),对照组80.67%(121/150),两组两年生存率差异有统计学意义(P<0.01),干预措施对Ⅱ期肿瘤患者两年生存率有明显的改善.进一步的分析表明:早、中期患者的两年生存率中,干预组88.03%(163/177),也明显高于对照组82.88%(184/222)(P<0.01).结论 以提高生存质量为目标的肿瘤学、心理学和社会医学多学科联合的综合康复干预有助于早、中期恶性肿瘤患者两年生存率的提高.

Objective To investigate the effect of multidisciplinary intervenient on survival of patients with malignant tumor. Methods Six hundred and thirty-nine malignant tumor patients were randomly assigned to the intervenient and the control group. A total of 584 completed the follow-up study. The intervenient group received comprehensive treatment for 2 years,while the control group was in a process of self-rehabilitation. The 2-year survival rate was compared between the groups by using Cox proportional hazard model. Results The 2-year survival rate was 94. 74% (108/114) or 80. 67% (121/150) in II stage patients of the intervenient or control group, respectively ( P < 0. 01 ) . The 2-year survival rate was 88. 03% (163/177) or 82. 8% (184/222) in early and medium stage patients of the intervenient or control group,respectively(P <0. 01). Conclusion The multidisciplinary intervenient may help to improve the 2 year survival of early or moderate stage malignant tumors.